Skip to main content

PT-141 Bremelanotide Efficacy

Meaning

PT-141 Bremelanotide Efficacy is the objective measure of the synthetic peptide Bremelanotide’s ability to successfully stimulate central melanocortin receptors, resulting in a clinically meaningful enhancement of sexual desire, arousal, and overall function. This efficacy is specifically evaluated in the context of treating sexual dysfunction, such as Hypoactive Sexual Desire Disorder (HSDD) in women and certain forms of erectile dysfunction in men. It quantifies the peptide’s therapeutic success in modulating the neuroendocrine pathways governing sexual response.